INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 18, 2006 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,966 | -- | 4,966 |
| Dec 18, 2006 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,034 | -- | 25,034 |
| Dec 18, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,921 | -- | 4,921 |
| Dec 18, 2006 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 70,079 | -- | 70,079 |
| Dec 18, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 404
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 250,000 |
| Dec 18, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,921 | -- | 4,921 |
| Dec 18, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 95,079 | -- | 95,079 |
| Dec 18, 2006 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,921 | -- | 4,921 |
| Dec 18, 2006 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 307,579 | -- | 307,579 |
| Dec 18, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 617
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,921 | -- | 4,921 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.